Serum vascular endothelial growth factor changes and safety after topical anti‐human VEGF antibody bevacizumab in healthy dogs

OBJECTIVE: To evaluate ocular and general safety of topical anti‐human VEGF bevacizumab and the effect on serum vascular endothelial growth factor (VEGF) values in healthy dogs. PROCEDURES: Nine university‐owned beagles received 0.05 mL of 0.25% bevacizumab eyedrops (Avastin(®), Roche) in one eye an...

Descripción completa

Detalles Bibliográficos
Autores principales: Muellerleile, Lisa‐Marie, Tichy, Alexander, Nell, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850477/
https://www.ncbi.nlm.nih.gov/pubmed/30716185
http://dx.doi.org/10.1111/vop.12628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850477/
https://www.ncbi.nlm.nih.gov/pubmed/30716185
http://dx.doi.org/10.1111/vop.12628

Ejemplares similares